FDA Drug recall D-764-2014
Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, In…
- FDA Drug
- Class I
- terminated
- Published 2014-01-29
On 2014-01-29 the FDA classified a Class I recall of Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, In… by Cubist Pharmaceuticals, citing presence of Particulate Matter; Glass particulates observed in vials.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-764-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-08-29 |
| Published | 2014-01-29 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Cubist Pharmaceuticals |
| Distribution | US |
Product
Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA
Reason
Presence of Particulate Matter; Glass particulates observed in vials
Identifiers
| code_info | Lot Numbers: Lot 950453F, Exp. 12/06/2013 Lot 090203F, Exp. 09/07/2014 Lot 201703F, Exp. 08/31/2015 Lot 201653F, Exp. 09/01/2015 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-764-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.